The approval also allows companies using OptiMSM® in their formulations to now feature joint health-related claims on product packaging.
The partnership, facilitated by GAIN, will support joint efforts in research, development, and knowledge exchange across food processing and nutrition technologies.
The move could impact American manufacturing, trade, and the US$285 billion soft drinks market, as health concerns intensify.
Ferment4Health will explore how bioactive compounds produced during fermentation, particularly postbiotics, interact with the gut microbiome and the immune system.